DRUG · Mapped RxNorm record
Daratumumab Injection
Normalized identity: daratumumab InjectionView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Study of Daratumumab in Patients With Mild to Moderate Alzheimer's Disease
NCT04070378
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedStudy of Daratumumab in Patients With Mild to Moderate Alzheimer's Disease
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Alzheimer Diseaseverified · MONDO: Alzheimer disease
Interventions
Daratumumab InjectionDRUG · verified · RxNorm: daratumumab Injection
Sponsors & collaborators
Marc L Gordon, MDlead sponsor
Janssen Scientific Affairs, LLCcollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04070378 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.